Charles River Laboratories International Inc. Stock Rises 6.2%, Outperforms Peers
Dow Jones2026/09/24 20:33This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Charles River Laboratories International Inc. advanced 6.2% to $294.44 on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index remaining mostly unchanged at 7,704.13 and the Dow Jones Industrial Average falling 0.3% to 51,349.98.
Charles River Laboratories International Inc. closed 2.9% short of its 52-week high of $303.31, which the company reached on August 27th.
The stock outperformed some of its peers, as Labcorp Holdings Inc. rose 1.6% to $308.95, Alnylam Pharmaceuticals Inc. rose 1.2% to $249.59, and Bio-Techne Corp. rose 0.07% to $72.57.
Trading volume totaled 1.6 million, compared to the 50-day average of 934,933.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
September 24, 2026 16:33 ET (20:33 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Anthropic "accidentally" leaks IPO documents! Plans to raise $69.3 billion, valuation drops from 2 trillion to 1.3 trillion
Anthropic mistakenly published and then withdrew a prospectus for a planned $69.3 billion fundraising, with its valuation dropping from a peak of $2 trillion to between $1.1 trillion and $1.3 trillion.
Subaru Publishes Transcript of First-Half FYE 2027 Financial Results Presentation
Citi: Occidental Petroleum (OXY.US) Q3 cash flow surpasses expectations, accelerated debt repayment cannot hide concerns over Q4 output
Citi published a research report maintaining Occidental Petroleum's "Neutral" rating, with a target price of $65.
WikiLeaks Founder Julian Assange Welcomes Daughter With Terminator Quote
Crypto prices
More
